血液系统恶性肿瘤中靶向 ROR1 的治疗进展 Therapeutic advances in the targeting of ROR1 in hematological cancers. PubMed 2024/11/17 发表Cell Death DiscovQ1 · IF 10.4(JCR 2025) 靶点:HER2靶点:EGFR靶点:ROR1技术:CAR-T技术:双特异性抗体血液系统恶性肿瘤
靶向肿瘤血管以改善经体外 T 细胞衔接双特异性抗体武装的 T 细胞的抗肿瘤活性 Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. PubMed 2023/03/01 发表J Immunother CancerQ1 · IF 11.7(JCR 2025) 靶点:GD2靶点:HER2靶点:GPC3技术:双特异性抗体神经母细胞瘤骨肉瘤